Company Number: 14006357

Analysis Date: 2025-07-29 19:00 UTC

Financial Health Assessment: CS3 CLINICAL LIMITED

---

1. Financial Health Score: D

Explanation:
The company is in the very early stages of its financial life, with minimal net assets (£206) and current assets just meeting current liabilities (net current assets = £206). The absence of significant fixed assets and very low working capital points to a fragile financial position. While the company is meeting its filing deadlines and is not in distress, the scale and scope of its financial resources are extremely limited, which constrains operational flexibility and growth capacity.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Current Assets	£206	Very low liquidity; cash or equivalents barely cover immediate needs.
Net Current Assets (Working Capital)	£206	Positive but marginal; indicates minimal buffer to cover short-term obligations.
Net Assets (Shareholders' Funds)	£206	Extremely low; business has minimal equity base.
Fixed Assets	£0	No investment in long-term assets, which may limit operational capacity or growth.
Average Employees	1	Very small operation; limited human resources.
Filing Status	Up to date	Good compliance with statutory obligations, no penalties or overdue filings.

---

3. Diagnosis: What the Financial Data Reveals About Business Health

CS3 CLINICAL LIMITED is a micro-entity operating in specialized cleaning services and appears to be a very small startup or early-stage business. The financial "vital signs" show a company that is just keeping its financial "heartbeat" alive but with very limited reserves or capital. The healthy symptom is the positive net current assets, meaning the company can cover its short-term liabilities—an essential sign of survival. However, the extremely low net assets and lack of fixed assets indicate a business that is vulnerable to any unexpected expenses or downturns. The single employee structure further suggests limited operational capacity.

The absence of debt is a positive note, implying no immediate financial distress or over-leverage. However, the company’s growth potential or ability to absorb shocks is minimal without fresh capital injection or revenue increase.

---

4. Prognosis: Future Financial Outlook

With current financial indicators, CS3 CLINICAL LIMITED faces a precarious future unless it can increase its asset base, generate consistent revenue, or secure additional funding. Its micro-entity status brings reduced filing burdens, which is suitable for its size, but the company needs to monitor its cash flow closely to avoid liquidity crises.

If the business can expand its client base, increase cash inflows, and reinvest in fixed assets or working capital, the prognosis improves significantly. Without growth or additional capital, the company risks stagnation or inability to sustain operations in the medium term.

---

5. Recommendations: Specific Actions to Improve Financial Wellness

• Increase Cash Reserves: Seek to build a stronger cash buffer to manage unexpected expenses, improving the "healthy cash flow" of the business.
• Develop Revenue Streams: Focus on expanding customer base or contracts to boost income, which will strengthen working capital and net assets.
• Invest in Fixed Assets: Consider gradual investment in tools or equipment that enhance operational efficiency and competitive advantage.
• Monitor Costs Closely: Maintain tight control over expenses to preserve the fragile net asset position and ensure obligations are met.
• Explore Funding Options: Look into potential equity investment or small business loans to provide capital for growth and stability.
• Maintain Compliance: Continue timely filings and governance to avoid penalties and maintain good standing with regulators.
• Plan for Growth: Prepare a detailed business plan focused on scaling operations and financial resilience.

---